- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Piramal Pharma Limited — Updates, 06-04-2026: General Updates
06-04-2026 | 06:32 pm
06-04-2026 | 06:32 pm
Piramal Pharma's ESG rating climbed to 64 for FY24-25, a notable improvement from 61 by NSE Sustainability. This highlights the company's strengthened commitment to sustainability and responsible operations, a positive for investor confidence.
No comments yet. Be the first to comment!